Lv1
100 积分 2024-03-23 加入
Ovarian cancer
16天前
已完结
Occupational health and safety risk assessment based on linguistic distribution preference relations and the gained and lost dominance score method
26天前
已关闭
Regional Heterogeneity and Future Challenges in Ovarian Cancer Burden in Asia
1个月前
已完结
Heterogeneous cellular responses to hyperthermia support combined intraperitoneal hyperthermic immunotherapy for ovarian cancer mouse models
1个月前
已完结
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
1个月前
已完结
Epigenetic Therapy in a Rare Ovarian Cancer — A Double-Edged Sword
1个月前
已完结
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
1个月前
已完结
Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
1个月前
已完结
Treatment of epithelial ovarian cancer
1个月前
已完结
PRC1 promotes ovarian cancer progression by binding to RPL4 and increasing MDM2-mediated p53 ubiquitination
1个月前
已完结
皖公网安备34019202002308
